Cargando…

Guangdong’s Study of the Effectiveness of China’s Inactivated Vaccines Against the SARS-CoV-2 B.1.617.2 (Delta) Variant

Detalles Bibliográficos
Autores principales: Wang, Fuzhen, An, Zhijie, Rodewald, Lance, Wu, Dan, Tang, Lin, Zheng, Hui, Liu, Qianqian, Gao, George F., Yin, Zundong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Editorial Office of CCDCW, Chinese Center for Disease Control and Prevention 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8392787/
https://www.ncbi.nlm.nih.gov/pubmed/34594978
http://dx.doi.org/10.46234/ccdcw2021.179
_version_ 1783743583505874944
author Wang, Fuzhen
An, Zhijie
Rodewald, Lance
Wu, Dan
Tang, Lin
Zheng, Hui
Liu, Qianqian
Gao, George F.
Yin, Zundong
author_facet Wang, Fuzhen
An, Zhijie
Rodewald, Lance
Wu, Dan
Tang, Lin
Zheng, Hui
Liu, Qianqian
Gao, George F.
Yin, Zundong
author_sort Wang, Fuzhen
collection PubMed
description
format Online
Article
Text
id pubmed-8392787
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Editorial Office of CCDCW, Chinese Center for Disease Control and Prevention
record_format MEDLINE/PubMed
spelling pubmed-83927872021-09-29 Guangdong’s Study of the Effectiveness of China’s Inactivated Vaccines Against the SARS-CoV-2 B.1.617.2 (Delta) Variant Wang, Fuzhen An, Zhijie Rodewald, Lance Wu, Dan Tang, Lin Zheng, Hui Liu, Qianqian Gao, George F. Yin, Zundong China CDC Wkly Commentary Editorial Office of CCDCW, Chinese Center for Disease Control and Prevention 2021-08-20 /pmc/articles/PMC8392787/ /pubmed/34594978 http://dx.doi.org/10.46234/ccdcw2021.179 Text en Copyright and License information: Editorial Office of CCDCW, Chinese Center for Disease Control and Prevention 2021 https://creativecommons.org/licenses/by-nc-sa/4.0/This work is licensed under a Creative Commons Attribution-NonCommercial-Share Alike 4.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/ (https://creativecommons.org/licenses/by-nc-sa/4.0/)
spellingShingle Commentary
Wang, Fuzhen
An, Zhijie
Rodewald, Lance
Wu, Dan
Tang, Lin
Zheng, Hui
Liu, Qianqian
Gao, George F.
Yin, Zundong
Guangdong’s Study of the Effectiveness of China’s Inactivated Vaccines Against the SARS-CoV-2 B.1.617.2 (Delta) Variant
title Guangdong’s Study of the Effectiveness of China’s Inactivated Vaccines Against the SARS-CoV-2 B.1.617.2 (Delta) Variant
title_full Guangdong’s Study of the Effectiveness of China’s Inactivated Vaccines Against the SARS-CoV-2 B.1.617.2 (Delta) Variant
title_fullStr Guangdong’s Study of the Effectiveness of China’s Inactivated Vaccines Against the SARS-CoV-2 B.1.617.2 (Delta) Variant
title_full_unstemmed Guangdong’s Study of the Effectiveness of China’s Inactivated Vaccines Against the SARS-CoV-2 B.1.617.2 (Delta) Variant
title_short Guangdong’s Study of the Effectiveness of China’s Inactivated Vaccines Against the SARS-CoV-2 B.1.617.2 (Delta) Variant
title_sort guangdong’s study of the effectiveness of china’s inactivated vaccines against the sars-cov-2 b.1.617.2 (delta) variant
topic Commentary
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8392787/
https://www.ncbi.nlm.nih.gov/pubmed/34594978
http://dx.doi.org/10.46234/ccdcw2021.179
work_keys_str_mv AT wangfuzhen guangdongsstudyoftheeffectivenessofchinasinactivatedvaccinesagainstthesarscov2b16172deltavariant
AT anzhijie guangdongsstudyoftheeffectivenessofchinasinactivatedvaccinesagainstthesarscov2b16172deltavariant
AT rodewaldlance guangdongsstudyoftheeffectivenessofchinasinactivatedvaccinesagainstthesarscov2b16172deltavariant
AT wudan guangdongsstudyoftheeffectivenessofchinasinactivatedvaccinesagainstthesarscov2b16172deltavariant
AT tanglin guangdongsstudyoftheeffectivenessofchinasinactivatedvaccinesagainstthesarscov2b16172deltavariant
AT zhenghui guangdongsstudyoftheeffectivenessofchinasinactivatedvaccinesagainstthesarscov2b16172deltavariant
AT liuqianqian guangdongsstudyoftheeffectivenessofchinasinactivatedvaccinesagainstthesarscov2b16172deltavariant
AT gaogeorgef guangdongsstudyoftheeffectivenessofchinasinactivatedvaccinesagainstthesarscov2b16172deltavariant
AT yinzundong guangdongsstudyoftheeffectivenessofchinasinactivatedvaccinesagainstthesarscov2b16172deltavariant